Bracanat 150Mg Tablet 30's

Bracanat 150mg Tablet contains Olaparib, an anticancer medicine primarily used in the treatment of various cancers, including ovarian and breast cancer.

Benefits

Olaparib functions as a PARP inhibitor, targeting and blocking an enzyme critical for DNA repair within cancer cells. This mechanism prevents cancer cells from repairing their damaged DNA, leading to their eventual death and slowing tumor growth, particularly in cells with BRCA mutations. It offers a targeted therapeutic approach, aiming to selectively impact cancer cells while potentially reducing severe effects on healthy cells compared to conventional chemotherapy.

Uses and Indications

• Maintenance therapy for ovarian cancer, especially in patients with BRCA gene mutations who have responded to platinum-based chemotherapy.
• Treatment for BRCA-mutated ovarian cancer.
• Management of breast cancer with BRCA mutations, including HER2-negative early or metastatic breast cancer.
• Treatment option for advanced pancreatic cancer with BRCA mutations.
• Therapy for specific prostate cancer types with BRCA or HRR gene mutations.

The Bracanat 150Mg Tablet contains:

• Olaparib 150 mg (active ingredient).

Dosage and Administration

1. Bracanat 150Mg Tablet is for oral administration and can be taken with or without food.
2. Swallow the tablets whole with water; do not crush, chew, break, open, or split them.
3. Take the medicine regularly and at approximately the same time each day to maintain consistent medication levels in the body.
4. The exact dosage and duration of treatment will be determined by your prescribing doctor.
5. If a dose is missed, take the next dose at its regularly scheduled time; do not take a double dose to compensate.

Storage and Disposal

• Store Bracanat 150Mg Tablet in its original packaging at room temperature, typically below 30°C.
• Keep the tablets away from excessive heat, moisture, and direct light.
• Ensure the medicine is kept out of reach of children and pets.
• Dispose of any unused or expired medicine according to the advice of your healthcare professional.

Precautions and Safety

• Regular blood tests are necessary to monitor blood cell counts (red, white, and platelets) and liver function throughout the treatment period.
• Avoid consuming grapefruit, grapefruit juice, or Seville oranges, as these can increase the risk of side effects.
• This medicine can be harmful to an unborn baby. Women of childbearing potential must use effective contraception during treatment and for at least 6 months after the last dose.
• Male patients with female partners of reproductive potential should use effective contraception during treatment and for at least 3 months after the last dose.
• Breastfeeding should be avoided during treatment, as it is not known if Olaparib passes into breast milk.
• Inform your doctor about any pre-existing medical conditions, such as lung, liver, heart, or kidney problems, and all other medications or supplements you are taking.
• Exercise caution when driving or operating heavy machinery if you experience dizziness or fatigue.
• This medicine may increase the risk of bone marrow problems, including myelodysplastic syndrome or acute myeloid leukemia, lung inflammation (pneumonitis), and blood clots.

Side Effects and Risks

• Common side effects include nausea, fatigue, vomiting, loss of appetite, diarrhea, dizziness, headache, and anemia (low red blood cell count).
• Report serious side effects to your doctor immediately, such as black or tarry stools, bleeding gums, bloody or cloudy urine, chest pain, chills, cough, fever, difficult urination, rapid heartbeat, unexplained bruising or bleeding, yellowing of skin or eyes, or any new or worsening breathing problems.

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.